Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,942 | Dovepress* | 6,915+ | 417 | 7,332 | |
| PubMed Central* | 2,027 | 473 | 2,500 | ||
| Totals | 8,942 | 890 | 9,832 | ||
| *Since 16 March 2022 | |||||
View citations on PubMed Central and Google Scholar